Novartis and Glaxo Deal Reshapes Pharma Industry - Presented by: The Aol. On Network

Novartis completed about $25 billion of transactions in its product portfolios, including the sale of two units to British-based GlaxoSmithKline. Hester Plumridge explains why the Swiss company is doing these deals now and what this means for the pharmaceutical industry.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
FB $ 74.11 1.75 ▼ 2.31%
ARCP $ 9.42 0.58 ▼ 5.80%
BAC $ 17.02 0.03 ▲ 0.18%
INTC $ 32.58 1.34 ▼ 3.95%
PBR $ 11.32 0.11 ▲ 0.98%
AVP $ 9.97 0.99 ▼ 9.03%
TWTR $ 41.80 0.28 ▼ 0.67%
AAPL $ 106.98 0.36 ▼ 0.34%

As of 10/30/2014, 04:15 PM
More Most Active